News
If a new experiment pans out, Medicaid and Medicare could begin covering the costly weight-loss drugs that price out many ...
Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural phenomenon.
The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.
Medicare is barred under a 2003 law from paying for weight-loss medications like Wegovy. Lawmakers on Thursday reintroduced a bill that would expand Medicare coverage to the drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback